ClearPoint Neuro, Inc. 8-K

What Happened On March 17, 2026, ClearPoint Neuro, Inc. (CLPT) filed a Form 8-K to announce its financial results for the fourth fiscal quarter and full year ended December 31, 2025. The company issued a press release reporting those results (furnished as Exhibit 99.1) and posted an updated investor presentation to its investor website (furnished as Exhibit 99.2). The filing was signed by CFO Danilo D’Alessandro.

Key Details

• Filing date: March 17, 2026; Items reported: Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
• Exhibit 99.1: Press release announcing Q4 and full-year 2025 results; Exhibit 99.2: Investor presentation (also posted at http://ir.stockpr.com/clearpointneuro/investor-presentations).
• Exhibit 104: Cover Page Interactive Data File (Inline XBRL) included.
• Form 8-K signed by CFO Danilo D’Alessandro.

Why It Matters This 8‑K makes ClearPoint Neuro’s latest quarterly and annual financial results and updated investor materials publicly available. Retail investors should review the press release and investor presentation (Exhibits 99.1 and 99.2) or the company’s investor webpage for specific earnings, revenue, and management commentary to assess company performance.